Holen Sie sich die Stockscreener-App
86.18
0.03%
-0.03
Handel nachbörslich:
86.18
Schlusskurs vom Vortag:
$86.21
Offen:
$85.71
24-Stunden-Volumen:
212.10K
Relative Volume:
0.57
Marktkapitalisierung:
$907.13M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+1.46%
1M Leistung:
+1.66%
6M Leistung:
-2.71%
1J Leistung:
-5.05%
1-Tages-Spanne:
$85.48
$86.52
1-Wochen-Bereich:
$84.79
$87.81
52-Wochen-Spanne:
$77.67
$99.51
Vaneck Pharmaceutical Etf Stock (PPH) Company Profile
Firmenname
Vaneck Pharmaceutical Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PPH
Vaneck Pharmaceutical Etf
|
86.18 | 907.13M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
286.72 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
583.08 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
585.87 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
226.76 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
514.00 | 124.43B | 0 | 0 | 0 | 0.00 |
Vaneck Pharmaceutical Etf Aktie (PPH) Neueste Nachrichten
Gilead and Vertex Pharma named among biotech’s tariff safe havens - MSN
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - sharewise
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Sold by Comerica Bank - Defense World
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Sold by Jane Street Group LLC - Defense World
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing DistortionCVS Health (NYSE:CVS), Cigna Group (NYSE:CI) - Benzinga
ETFs to Capitalize on the Novo Nordisk-Septerna Deal - Yahoo Finance
Do Wall Street Analysts Like Cencora Stock? - inkl
PPH, Big Pharma Stocks Volatile on Trump Drug Pricing - ETF.com
Stock ETFs Surge on China Tariffs Pact; Bonds, Gold Falter - Yahoo Finance
Biopharma Stocks Rise as Trump Orders Drug Price Cuts - Genetic Engineering and Biotechnology News
ETFs on the Move Post U.S.-China Trade Deal - Nasdaq
Pharma ETFs in Focus on Trump's Drug Price Overhaul - Yahoo Finance
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - NewsBreak: Local News & Alerts
Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks - Benzinga
A Look at Pharma ETFs After Strong Q1 Earnings - Yahoo Finance
Stock Traders Purchase High Volume of VanEck Pharmaceutical ETF Put Options (NASDAQ:PPH) - Defense World
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Well-Timed Bearish Drug ETF Bet Pays Off on Vaccine Chief News - Bloomberg
India proposes zero-for-zero tariff deal on U.S. auto parts, steelreport - Seeking Alpha
Envestnet Asset Management Inc. Has $499,000 Stock Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Raymond James Financial Inc. Acquires New Stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - Yahoo Finance
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Bought by JPMorgan Chase & Co. - Defense World
Where to Invest $10,000 Right Now - Bloomberg.com
VanEck Pharmaceutical ETF Target of Unusually High Options Trading (NASDAQ:PPH) - Defense World
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - Nasdaq
ETFs in Focus Post JNJ's Q1 Earnings Beat, Dividend Hike - TradingView
Trump says pharma tariffs are coming in the “not-too-distant-future” - Seeking Alpha
PPH: Will Overcome Tariffs, But Competitor Funds Look Stronger (NASDAQ:PPH) - Seeking Alpha
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Sold by National Bank of Canada FI - The AM Reporter
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies - Benzinga
Pharma, MedTech stocks bounce back as Trump pauses most tariffs - Seeking Alpha
LPL Financial LLC Sells 35,154 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Trump says 'major tariff on pharmaceuticals' coming soon (PPH:NASDAQ) - Seeking Alpha
StockWatch: Biopharma Funds Tumble with Wall Street as Industry Spared from Worst of Tariffs—for Now - Genetic Engineering and Biotechnology News
Big Pharma higher after tariff exemption despite ongoing uncertainties - MSN
Raymond James Financial Inc. Invests $1.32 Million in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Big Pharma drops sharply ahead of Trump’s tariff announcement - MSN
Top Semiconductor Companies to Watch in 2025 - VanEck
U.S. Consumers To Be Hit Hardest By Pharmaceutical Tariffs - Seeking Alpha
Commonwealth Equity Services LLC Buys 631 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Sold by US Bancorp DE - Defense World
Assetmark Inc. Has $86,000 Stock Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
SBI Securities Co. Ltd. Makes New Investment in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Jones Financial Companies Lllp Acquires 5,408 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Finanzdaten der Vaneck Pharmaceutical Etf-Aktie (PPH)
Es liegen keine Finanzdaten für Vaneck Pharmaceutical Etf (PPH) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
0.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):